Quick Answer
TG THERAPEUTICS, INC. reported Stockholders Equity of $648.02 million for fiscal year 2025.
TG THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $648.02M | +191.4% |
| 2024 | $222.36M | +38.5% |
| 2023 | $160.50M | +174.0% |
| 2022 | $58.59M | -75.3% |
| 2021 | $237.15M | -54.3% |
| 2020 | $519.35M | +1244.9% |
| 2019 | $38.62M | +60.7% |
| 2018 | $24.04M | -64.1% |
| 2017 | $66.99M | +86.8% |
| 2016 | $35.87M | -64.7% |
| 2015 | $101.57M | +26.8% |
| 2014 | $80.10M | +100.0% |
| 2013 | $40.05M | +157.6% |
| 2012 | $15.55M | +61.6% |
| 2011 | $9.62M | — |
| 2010 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $607.22M | +216.0% | +119.7% |
| June 30, 2025 | $276.43M | +55.7% | +16.5% |
| March 31, 2025 | $237.29M | +48.2% | +6.7% |
| December 31, 2024 | $222.36M | +38.5% | +15.7% |
| September 30, 2024 | $192.16M | +16.6% | +8.2% |
| June 30, 2024 | $177.57M | +338.9% | +10.9% |
| March 31, 2024 | $160.11M | +483.6% | -0.2% |
| December 31, 2023 | $160.50M | +174.0% | -2.6% |
- TG THERAPEUTICS, INC. showed an increase of +191.4% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from TG THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: